All(n = 168) | Men(n = 99) | Women(n = 69) | |
---|---|---|---|
Comorbidity disease, n (%) | |||
MI | 22 (13.10) | 13 (13.13) | 9 (13.04) |
CHD | 20 (11.90) | 17 (17.17) | 3 (4.35) |
PAOD | 6 (3.57) | 3 (3.03) | 3 (4.35) |
CVD | 98 (58.33) | 68 (68.69) | 30 (43.48) |
SD | 11 (6.55) | 2 (2.02) | 9 (13.04) |
COPD | 20 (11.90) | 11 (11.11) | 9 (13.04) |
CTD | 6 (3.57) | 0 (0) | 6 (8.70) |
GU | 49 (29.17) | 31 (31.31) | 18 (26.09) |
DM | 65 (38.69) | 50 (50.51) | 15 (21.74) |
CKD | 22 (13.10) | 13 (13.13) | 9 (13.04) |
HP | 2 (1.19) | 2 (2.02) | 0 (0) |
CL | 0 (0) | 0 (0) | 0 (0) |
ML | 1 (0.60) | 1 (1.01) | 0 (0) |
tumor | 49 (29.17) | 28 (28.28) | 21 (30.43) |
LD | 14 (8.33) | 11 (11.11) | 3 (4.35) |
CCI score, n (%) | |||
4 | 11 (6.55) | 4 | 7 |
5 | 33 (19.64) | 7 | 26 |
6 | 54 (32.14) | 33 | 21 |
7 | 24 (14.29) | 21 | 3 |
8 | 22 (13.10) | 22 | 0 |
9 | 7 (4.17) | 4 | 3 |
10 | 3 (1.79) | 3 | 0 |
11 | 5 (2.98) | 2 | 3 |
12 | 8 (4.76) | 2 | 6 |
13 | 1 (0.60) | 1 | 0 |